PubMed:12618764 / 0-127
Annnotations
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-127 | Sentence | denotes | MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. |
| T1 | 0-127 | Sentence | denotes | MEK5 overexpression is associated with metastatic prostate cancer, and stimulates proliferation, MMP-9 expression and invasion. |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 12618764-0#0#4#gene5607 | 0-4 | gene5607 | denotes | MEK5 |
| 12618764-0#39#65#diseaseC0936223 | 39-65 | diseaseC0936223 | denotes | metastatic prostate cancer |
| 12618764-0#39#65#diseaseC1282496 | 39-65 | diseaseC1282496 | denotes | metastatic prostate cancer |
| 0#4#gene560739#65#diseaseC0936223 | 12618764-0#0#4#gene5607 | 12618764-0#39#65#diseaseC0936223 | associated_with | MEK5,metastatic prostate cancer |
| 0#4#gene560739#65#diseaseC1282496 | 12618764-0#0#4#gene5607 | 12618764-0#39#65#diseaseC1282496 | associated_with | MEK5,metastatic prostate cancer |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T69 | 0-4 | gene:5607 | denotes | MEK5 |
| T70 | 39-65 | disease:C0936223 | denotes | metastatic prostate cancer |
| R1 | T69 | T70 | associated_with | MEK5,metastatic prostate cancer |
| R2 | T69 | T70 | associated_with | MEK5,metastatic prostate cancer |
CoMAGC
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-4 | Gene | denotes | MEK5 |
| E1 | 5-19 | Gene_expression | denotes | overexpression |
| E2 | 5-19 | Positive_regulation | denotes | overexpression |
| T2 | 50-65 | prostate cancer | denotes | prostate cancer |
| R1 | T1 | E1 | themeOf | MEK5,overexpression |
| R2 | E1 | E2 | themeOf | overexpression,overexpression |
| R3 | T1 | T2 | CGE-increased | MEK5,prostate cancer |
| R4 | T1 | T2 | CCS-normalTOcancer | MEK5,prostate cancer |
| R5 | T1 | T2 | PT-causality | MEK5,prostate cancer |
| R3 | T1 | T2 | IGE-unchanged | MEK5,prostate cancer |